| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.061 | 0.1 |